Crohn’s disease is not typically fatal, but it does shorten life expectancy and carries real risks of life-threatening complications. Large population studies show that people with Crohn’s live roughly 5 to 8 fewer years than the general population, with the gap slightly larger for women (6.6 to 8.1 years) than men (5.0 to 6.1 years). The good news is that most people with Crohn’s live long lives, and the mortality gap has been narrowing as treatments improve.
How Much Does Crohn’s Raise the Risk of Death?
Studies across multiple countries have consistently found that people with Crohn’s disease have a higher mortality rate than the general population, though the size of that increase varies. The standardized mortality ratio, which compares deaths in Crohn’s patients to what would be expected in people of the same age and sex, ranges from about 1.2 to 1.9 across major population studies. In practical terms, that means Crohn’s patients face roughly 20% to 90% higher mortality than their peers, depending on the population studied.
After adjusting for age, sex, and cigarette smoking, one large UK study found the risk of death was 73% higher in Crohn’s patients than in matched controls. Another study calculated a 10-year risk of death at 10% for Crohn’s patients compared to 7% in the general population. These numbers sound alarming, but they reflect averages across all patients, including those diagnosed at older ages or with more aggressive disease. Many people with well-managed Crohn’s face much smaller increases in risk.
What Makes Crohn’s Dangerous
Crohn’s disease itself rarely kills directly. The danger comes from complications that develop when the disease is poorly controlled or when inflammation persists over years.
Fistulas, which are abnormal tunnels that form between the intestine and other organs or the skin, can lead to deep infections and pockets of pus called abscesses. Left untreated, abdominal abscesses can become life-threatening. Toxic megacolon, a condition where the colon rapidly dilates and stops functioning, occurs in 1% to 5% of people with Crohn’s affecting the colon. When caught early and treated surgically before the bowel perforates, mortality is 2% to 8%. If the bowel has already ruptured, that number jumps to around 40%.
Severe intestinal bleeding, bowel obstruction, and widespread infection (sepsis) are other acute emergencies that can occur. These complications are treatable when caught quickly, which is why recognizing warning signs matters.
Blood Clots: A Hidden Risk
One of the less obvious dangers of Crohn’s is an elevated risk of blood clots. About 5.7% of Crohn’s patients develop a clot at some point, and this complication carries serious consequences. In one large study, Crohn’s patients who developed blood clots had a death rate of 15.8%, compared to 1.4% in those without clots. After accounting for other factors, having a blood clot episode was associated with an 11-fold increase in the odds of dying.
Pulmonary embolism, where a clot travels to the lungs, is the most dangerous form, with mortality exceeding 15% in the first three months. Active inflammation, hospitalization, and immobility all increase clot risk. This is one reason doctors pay close attention to clot prevention during Crohn’s flares requiring hospitalization.
Cancer Risk With Long-Standing Disease
Chronic intestinal inflammation raises the risk of developing cancer in the affected areas. People with Crohn’s have roughly double the risk of colorectal cancer compared to the general population. The risk is higher when the colon is involved: about 3.3 times higher with colonic disease and 4.5 times higher when both the small and large intestines are affected.
Small bowel cancer, while still rare in absolute terms, is dramatically more common in Crohn’s patients. The risk is about 17 times higher than in the general population, and for those with disease concentrated in the ileum (the lower part of the small intestine), the increase reaches roughly 45-fold. These cancers are uncommon even in Crohn’s patients, but regular screening and surveillance colonoscopies are an important part of long-term care for this reason.
Who Faces the Highest Risk
Not everyone with Crohn’s faces the same level of danger. Several factors push mortality risk higher. Being diagnosed after age 40 roughly doubles the mortality ratio. Disease that involves the colon at diagnosis carries about twice the expected mortality. And paradoxically, patients whose disease initially appears purely inflammatory (without narrowing or fistulas) also show higher mortality ratios, possibly because their disease is underestimated early on.
Very early-onset Crohn’s, diagnosed in children under five, tends to present with more severe disease and carries disproportionately high rates of complications. Mortality also increases with age, with the heaviest burden in adults over 85. Men consistently have higher mortality rates than women. People living in rural areas face slightly higher mortality, likely reflecting differences in access to specialized care.
How Surgery Factors In
Many people with Crohn’s eventually need surgery to remove damaged sections of intestine. When performed as a planned (elective) procedure, the mortality risk is low: about 0.6%. Emergency surgery, typically done for perforation, uncontrolled bleeding, or obstruction, carries a significantly higher risk at around 3.6%. This six-fold difference is one of the strongest arguments for staying on top of Crohn’s management rather than letting complications escalate to the point where emergency intervention is the only option.
Treatment Risks Worth Understanding
The medications that keep Crohn’s in check, particularly biologics and immune-suppressing drugs, work by dialing down the immune system. This creates a trade-off: less inflammation but greater vulnerability to infections. Combining a biologic with steroids raises the risk of serious infection by about 64% compared to using the biologic alone. Adding an immune-suppressing pill to a biologic increases the risk by about 19%.
Long-term steroid use in particular has been linked to increased risk of death and cardiovascular events compared to biologic therapy alone, especially in Crohn’s patients. This is why gastroenterologists generally aim to get patients off steroids and onto maintenance therapies that control inflammation without the same long-term toll. Serious infections from these medications, including rare opportunistic infections like tuberculosis, can be fatal but remain uncommon with proper monitoring.
Signs That Need Immediate Attention
Certain symptoms during a Crohn’s flare signal a potential emergency. Fever combined with severe abdominal pain could indicate an abscess or perforation. Blood in the stool, especially in large amounts, may mean serious intestinal bleeding. Nausea and vomiting with a distended abdomen can signal a bowel obstruction. Sudden chest pain or shortness of breath, particularly during a flare or hospitalization, could point to a blood clot in the lungs. Diarrhea lasting more than two weeks, unexplained weight loss, or any combination of these symptoms with fever all warrant prompt medical evaluation.
The Outlook Is Improving
Despite the elevated risks, Crohn’s disease mortality has been declining over the past several decades as biologic therapies have become standard care. Life expectancy for women with Crohn’s has increased significantly in recent years. One encouraging finding from the research: use of biologic medications was independently associated with a lower odds of death, with an 80% reduction in risk compared to those not receiving biologics. The disease remains serious, but for most people diagnosed today and receiving modern treatment, Crohn’s is a chronic condition to manage rather than a fatal diagnosis.